A detailed history of Bank Of America Corp transactions in Amgen Inc stock. As of the latest transaction made, Bank Of America Corp holds 3,327,752 shares of AMGN stock, worth $1.02 Billion. This represents 0.09% of its overall portfolio holdings.

Number of Shares
3,327,752
Previous 4,260,796 21.9%
Holding current value
$1.02 Billion
Previous $1.23 Billion 22.9%
% of portfolio
0.09%
Previous 0.12%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $251 Million - $303 Million
-933,044 Reduced 21.9%
3,327,752 $946 Million
Q4 2023

Feb 14, 2024

SELL
$255.7 - $288.46 $39 Million - $44 Million
-152,429 Reduced 3.45%
4,260,796 $1.23 Billion
Q2 2023

Aug 14, 2023

SELL
$214.27 - $253.37 $346 Million - $410 Million
-1,616,284 Reduced 26.81%
4,413,225 $980 Million
Q1 2023

May 12, 2023

BUY
$225.79 - $275.2 $30.5 Million - $37.2 Million
135,127 Added 2.29%
6,029,509 $1.46 Billion
Q4 2022

Feb 10, 2023

SELL
$229.03 - $291.01 $200 Million - $254 Million
-871,882 Reduced 12.89%
5,894,382 $1.55 Billion
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $68.3 Million - $77 Million
-304,126 Reduced 4.3%
6,766,264 $1.53 Billion
Q2 2022

Aug 12, 2022

SELL
$230.71 - $256.74 $26.5 Million - $29.5 Million
-114,741 Reduced 1.6%
7,070,390 $1.72 Billion
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $275 Million - $304 Million
1,253,320 Added 21.13%
7,185,131 $1.74 Billion
Q4 2021

Feb 08, 2022

SELL
$198.88 - $227.6 $166 Million - $190 Million
-836,050 Reduced 12.35%
5,931,811 $1.33 Billion
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $18.6 Million - $21.7 Million
87,415 Added 1.31%
6,767,861 $1.44 Billion
Q2 2021

Sep 13, 2021

BUY
$233.58 - $259.14 $1.56 Billion - $1.73 Billion
6,680,446 New
6,680,446 $1.63 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $164B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.